INDP

Indaptus Therapeutics, Inc. - Common Stock (INDP)

About Indaptus Therapeutics, Inc. - Common Stock (INDP)

Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Details

Daily high

$1.02

Daily low

$0.93

Price at open

$1.00

52 Week High

$8.57

52 Week Low

$0.92

Market cap

113.2M

Dividend yield

Volume

37,378

Avg. volume

136,051

P/E ratio

-.14

Indaptus Therapeutics, Inc. - Common Stock News